Through the last year of the COVID-19 pandemic, healthcare workers have been on the front lines, bearing the brunt of the challenging circumstances. And, in an attempt to repay…
Search Results for: CYBN.NE – Page 3
Cybin (CYBN.NE) announced they are sponsoring Kernel’s feasibility study of its Kernel Flow technology to measure Ketamine’s psychedelic effect on cerebral cortex hemodynamics. Cybin announced in January that they…
Cybin (CYBN.NE) announced they have filed an international patent application that brings the potential to obtain patent coverage in 153 countries. Read full article here: https://equity.guru/2021/05/26/cybin-cybn-ne-files-international-patent-application-with-pct/…
Cybin (CYBN.NE) announced they have filed an international patent application that brings the potential to obtain patent coverage in 153 countries. The application is governed by the Patent Cooperation…
‘Growth hacking’ Early on in the shroom boom critics had one major pain point – legalization is too far away. I remember the stiffs at the Cannacord conference a…
Cybin (CYBN.NE) announced that the Institutional Review Board (IRB) has granted them approval to begin the study of its sublingual psilocybin formulation, CYB001, in a Phase II clinical trial…
They seem to have been born that way. They are naturally incapable of grasping and developing a manner of living which demands rigorous honesty. Today Alcoholics Anonymous (AA) is…
Cybin (CYBN.NE) announced that the Institutional Review Board (IRB) has granted them approval to begin the study of its sublingual psilocybin formulation, CYB001, in a Phase II clinical trial…
Last week Cybin (CYBN.NE) announced it was targetting alcoholism with its novel psychedelic compound CYB003. Another EG staffer wrote a piece last Monday outlining the details of the plan,…